News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Dr. Anthony Fauci, Dr.Moncef Slaoui and Top COVID…
Anthony Fauci, M.D., National Institute of Allergy and Infectious Diseases Director and Moncef Slaoui, Ph.D., U.S. Operation Warp Speed Chief Advisor will speak on a special plenary session on Tuesday, June 9 during BIO Digital, a virtual conference…
Modernized Biotech Regulation Will Unleash…
The U.S. Department of Agriculture (USDA) released today a modernized, science-based regulatory system for plant biotechnology aimed at maintaining oversight while driving innovation. Now government and industry must do more to build an informed and…
BIO Appoints a Physician-Scientist as New…
Immunologist Michelle McMurry-Heath is Selected  for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will Succeed Industry Leader Jim Greenwood  on June 1 as Leader of World’s Largest Biotechnology…
Letters, Testimony, & Comments
An Inclusive and Impactful Approach to…
The U.S. government’s regulatory approach cannot exist in isolation. It should be supported by credible transparency measures. A proactive approach to transparency stands to build trust and foster an inclusive environment to address our most…
Congressional Letter to FDA Commissioner…
In recent years advances in animal genetics have provided significant breakthroughs that can help to address some of society's most difficult challenges. These technologies can treat and protect animals from illness; limit the transmission of…
Senate Letter to Administration to Reject RFS…
We urge you to direct the EPA to reject all calls to waive the RFS. The RFS is more important now than ever as farmers, the biofuel sector, and rural America struggle to remain operating amid the COVID-19 crisis.
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Beyond Imaagination
May 29, 2020
Our Biotechnology: Beyond Imagination series highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature is Sutro Biopharma, a clinical stage…
BIO Digital 2020 Speakers Announced
May 28, 2020
We are living in an uncertain world, desperate to find solutions and feel safe again. The biotech industry has been working overtime, pushing the boundaries of science to discover vaccines, treatments and new modes of…
Emissions plant
May 28, 2020
Ever hear the saying, “Tidy room, tidy mind?” It’s common sense lore reiterating that we are inextricably linked to our environments. The concept applies even when the stakes are higher than a pile of laundry. If…